News24 Business | Aspen bulks up footprint in China with nearly R2bn acquisition of drug portfolio

SA's biggest pharmaceutical group, Aspen Pharmacare, has agreed to buy the Chinese subsidiary of Swiss drugmaker Sandoz for €92.6 million (R1.88 billion).